Efficacy of Linaclotide in Type II Diabetics With Chronic Constipation

PHASE4Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 1, 2015

Primary Completion Date

October 30, 2024

Study Completion Date

January 30, 2025

Conditions

Chronic ConstipationDiabete Mellitus

Interventions

DRUG

linaclotide or placebo

Trial Locations (1)

Texas Tech University Health Sciences Center, El Paso

All Listed Sponsors

lead

Texas Tech University Health Sciences Center, El Paso

OTHER

NCT03119584 - Efficacy of Linaclotide in Type II Diabetics With Chronic Constipation | Biotech Hunter | Biotech Hunter